Document:

MasterCard Senior Executive Annual Incentive Compensation Plan

  
 Exhibit 10.2

 MASTERCARD 
 SENIOR EXECUTIVE ANNUAL INCENTIVE COMPENSATION PLAN 
 As Amended and
Restated effective September 21, 2010 
 MasterCard Incorporated and subsidiaries (collectively or individually, as the context
requires, the “Company”) has adopted the MasterCard Senior Executive Annual Incentive Compensation Plan (the “Plan”) to reward senior executives for successfully achieving performance goals that are in direct support of corporate
and business unit/regional goals. 
 ARTICLE I 
 DEFINITIONS 
 Section 1.1 “Board” shall mean the Board of
Directors of the Company. 
 Section 1.2 “Code” shall mean the Internal Revenue Code of 1986, as amended. Any
reference to a section of the Code herein shall be deemed to include a reference to the regulations promulgated under such section. 
 Section 1.3 “Committee” shall mean the Human Resources and Compensation Committee of the Board of Directors of the Company, or such other committee or subcommittee designated by the Board
to administer the Plan. 
 Section 1.4 “Disability” shall mean total and permanent disability in accordance with
the Company’s long-term disability plan, as determined by the Committee. 
 Section 1.5 “Executive Officer”
shall mean a person who is a member of the Company’s Executive Committee, or its equivalent. 
 Section 1.6
“Participant” shall mean, with respect to any Performance Period, any Executive Officer selected by the Committee to participate in the Plan with respect to that Performance Period. 

Section 1.7 “Performance Period” shall mean a period of no less than 90 days for which incentive compensation shall be
paid hereunder, as established by the Committee. 
 ARTICLE II 

BONUS AWARDS 
 Section 2.1 Performance Targets. 
 (a) The Committee (or subcommittee
described in Section 6.1(a) below), will establish performance targets for each Performance Period. The performance targets for a Performance Period shall be based upon one or more of the following objective business criteria: (i) revenue;
(ii) earnings (including earnings before interest, taxes, depreciation and amortization, earnings before interest and taxes, and earnings before or after taxes); (iii) operating income; (iv) net income; (v) profit or operating
margins; (vi) earnings per share; (vii) return on assets; (viii) return on equity; (ix) return on invested capital; (x) economic value-added; (xi) stock price; (xii) gross dollar volume; (xiii) total
shareholder return; (xiv) market share; (xv) book value; (xvi) expense 

  
 1 

 
management; (xvii) cash flow, and (xviii) customer satisfaction. The foregoing criteria may relate to the Company, one or more of its affiliated employers or subsidiaries or one or more
of its divisions, regions or units, or any combination of the foregoing, and may be applied on an absolute basis and/or be relative to one or more peer group companies or indices, or any combination thereof, all as the Committee shall determine. In
establishing performance targets under Section 2.1(b) based on these objective business criteria, the Committee may provide that the targets shall be adjusted to reflect specified extraordinary, unusual and/or non-recurring items. 

(b) The performance targets shall be established by the Committee (or subcommittee) for a Performance Period (i) while the outcome
for that Performance Period is substantially uncertain and (ii) no more than 90 days or, if less, the number of days which is equal to 25 percent of the relevant Performance Period, after the commencement of the Performance Period to which the
performance target relates, or as otherwise permitted pursuant to Section 162(m) of the Code (or any successor section thereto). 
 Section 2.2 Bonus Awards. 
 (a) The maximum bonus award payable to any
Participant with respect to any calendar year of the Company shall not exceed $6,000,000. 
 (b) Prior to the payment of a bonus
award to any Participant, the Committee (or subcommittee described in Section 6.1(a) below) shall certify in writing the level of performance attained for the Performance Period to which such bonus award relates. The Committee shall have no
discretion to increase the amount of a Participant’s maximum bonus award that would otherwise be payable to the Participant upon the achievement of specified levels of the performance target established by the Committee, however, the Committee
may exercise negative discretion to make an award to any Participant for any Performance Period in an amount that is less than such maximum bonus award. 
 ARTICLE III 
 PAYMENT OF BONUS AWARD 

Section 3.1 Form of Payment. Each Participant’s bonus award shall be paid in cash. 

Section 3.2 Timing of Payment. Unless otherwise elected by the Participant pursuant to Section 3.3
below, each bonus award shall be paid in the first 2 1/2 months of the year following the end of the Performance Period. 

Section 3.3 Deferral of Payment. Payments of bonus awards under the Plan are eligible for deferral as allowed under the
MasterCard Incorporated Deferral Plan. 
 ARTICLE IV 

BONUS AWARD RECOUPMENT POLICY 
 Section 4.1 Recoupment. In the event of a restatement of materially inaccurate financial results, the Committee has the discretion to recover bonus awards that were paid under the Plan to a
Participant with respect to the period covered by the restatement as set forth herein. If the payment of a bonus award would have been lower had the achievement of applicable financial performance targets been calculated based on such restated
financial results, the Committee may, if it determines appropriate in its sole discretion, to the extent permitted by law, recover from the Participant the portion of the bonus award paid in excess of the payment that would have been made based on
the restated financial results. The Company will not seek to recover bonus awards paid more 

  
 2 

 
than three years after the date the Company files the report with the Securities and Exchange Commission that contained the incorrect financial results. This Article IV is in addition to, and not
in lieu of, any requirements under the Sarbanes-Oxley Act and shall apply notwithstanding anything to the contrary in the Plan. 

ARTICLE V 

TRANSFERS, TERMINATIONS AND NEW EXECUTIVE OFFICERS 
 Section 5.1 Terminations. A Participant who, whether voluntarily or involuntarily, is terminated, demoted, transferred or otherwise ceases to be an Executive Officer (otherwise than by death
or disability) at any time prior to the date a bonus award is paid in respect of a Performance Period shall not be eligible to receive any bonus award with respect to such Performance Period. In the event of a Participant’s death during a
Performance Period or prior to the date a bonus award is paid in respect of a Performance Period, the Participant shall receive within 75 days of death the target award payable for the Performance Period of the Participant’s death. In the event
of a Participant’s termination by reason of disability during the Performance Period or prior to the date a bonus award is paid in respect of a Performance Period, the Participant shall receive within 75 days of such termination a partial
target award, prorated based on the portion of the Performance Period that elapsed prior to such termination of employment by reason of disability. 
 ARTICLE VI 
 ADMINISTRATION 

Section 6.1 Administration. 
 (a) The Plan shall be administered by the Committee, which may delegate its duties and powers in whole or in part to any subcommittee thereof; it is expected that, in the event the Committee is not
comprised solely of “outside directors” within the meaning of Section 162(m) of the Code, a subcommittee comprised solely of at least two individuals who qualify as “outside directors” within the meaning of
Section 162(m) of the Code (or any successor section thereto) shall establish and administer the performance targets and certify that the performance targets have been attained; provided, however, that the failure of the
subcommittee to be so constituted shall not impair the validity of any bonus award granted by such subcommittee. 
 (b) It shall
be the duty of the Committee to conduct the general administration of the Plan in accordance with its provisions. The Committee shall have the power to interpret the Plan, and to adopt such rules for the administration, interpretation and
application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. The Committee’s decisions or actions in respect thereof shall be conclusive and binding upon any and all Participants and their beneficiaries,
successors and assigns, and all other persons. 
 ARTICLE VII 

OTHER PROVISIONS 
 Section 7.1 Term. This Plan, as amended June 7, 2010, shall be effective as of the annual meeting of stockholders in 2010 at which the Plan is approved, with respect to bonus awards granted on
or after the date of that meeting. 
 Section 7.2 Amendment, Suspension or Termination of the Plan. This Plan does
not constitute a promise to pay and may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Board or the Committee; provided, however, that any such amendment or
modification shall comply with all applicable laws and applicable requirements for exemption (to the extent necessary) under Section 162(m) of the Code. 

  
 3 

  
 Section 7.3
Approval of Plan by Stockholders. The Plan shall be submitted for the approval of the Company’s stockholders at the annual meeting of stockholders to be held in 2010. In the event that the Plan is not so approved, no bonus award shall be
payable under the Plan, and the Plan shall terminate and shall be null and void in its entirety. 
 Section 7.4 Bonus
Awards and Other Plans. Nothing contained in the Plan shall prohibit the Company from granting awards or authorizing other compensation to any Executive Officer under any other plan or authority or limit the authority of the Company to establish
other special awards or incentive compensation plans providing for the payment of incentive compensation to the Executive Officers. 
 Section 7.5 Miscellaneous. 
 (a) The Company shall deduct all federal,
state and local taxes required by law to be withheld from any bonus award paid to a Participant hereunder. 
 (b) In no event
shall the Company be obligated to pay to any Participant a bonus award for a Performance Period by reason of the Company’s payment of a bonus award to such Participant in any other Performance Period. 

(c) The rights of Participants under the Plan shall be unfunded and unsecured. Amounts payable under the Plan are not and will not be
transferred into a trust or otherwise set aside, except as provided in the MasterCard Incorporated Deferral Plan, in the event of a deferral thereunder. The Company shall not be required to establish any special or separate fund or to make any other
segregation of assets to assure the payment of any bonus award under the Plan. 
 (d) Nothing in this Plan or in any instrument
executed pursuant hereto shall confer upon any person any right to continue in the employment or other service of the Company, or shall affect the right of the Company to terminate the employment or other service of any person at any time with or
without cause. 
 (e) No rights of any Participant to payments of any amounts under the Plan shall be sold, exchanged,
transferred, assigned, pledged, hypothecated or otherwise disposed of other than by will or by laws of descent and distribution, and any such purported sale, exchange, transfer, assignment, pledge, hypothecation or disposition shall be void.

 (f) Any provision of the Plan that is prohibited or unenforceable shall be ineffective to the extent of such prohibition or
unenforceability without invalidating the remaining provisions of the Plan. 
 (g) The validity, construction, interpretation
and administration of the Plan and any bonus awards under the Plan and of any determinations or decisions made thereunder, and the rights of all persons having or claiming to have any interest herein or thereunder, shall be governed by, and
determined exclusively in accordance with, the laws of New York (determined without regard to its conflict of laws provisions). 

  
 4Omnibus Amendment to Receivables Sale Agreements

 Exhibit 10.1 
 EXECUTION COPY 
 OMNIBUS AMENDMENT TO

 RECEIVABLES SALE AGREEMENTS 
 THIS OMNIBUS AMENDMENT TO EACH OF THE RECEIVABLES SALE AGREEMENTS SET FORTH ON SCHEDULE I ATTACHED HERETO (each, a “Receivables Sale Agreement” and collectively, the
“Receivables Sale Agreements”), dated as of October 27, 2010 (this “Amendment”), is entered into among each of the originators (collectively, the “Originators”), and each of the buyers
(collectively, the “Buyers”) party to the Receivables Sale Agreements. 
 RECITALS 

1. Concurrently herewith, the Buyers, PNC Bank, National Association, as administrative agent (the “Administrative
Agent”) and each of the other parties thereto are entering into that certain Amended and Restated Credit and Security Agreement (the “Credit and Security Agreement”), dated as of the date hereof. 

2. The parties hereto desire to amend each of the Receivables Sale Agreements as hereinafter set forth. 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto hereby agree as follows: 
 1. Certain Defined Terms. Capitalized terms that are used herein
without definition and that are defined in, or by reference in, Exhibit I to the applicable Receivables Sale Agreement shall have the same meanings herein as therein defined. 

2. Amendments to the Receivables Sale Agreements. Each of the Receivables Sale Agreements is hereby amended as follows:

 (a) The fourth paragraph of the Preliminary Statements of the Receivables Sale Agreements is replaced in its
entirety with the following: 
 Buyer plans to finance its purchase of Gift Shop Receipts, Private Receivables
and Participation Interests in part by borrowing pursuant to that certain Amended and Restated Credit and Security Agreement dated as of October 27, 2010 (as amended, restated, replaced and/or otherwise modified from time to time in accordance
with the terms thereof, the “Credit and Security Agreement”) among Buyer and certain of its Affiliates, as joint and several borrowers, Parent, as Performance Guarantor, UHS of Delaware, Inc., as initial Servicer, Market
Street Funding LLC, Victory Receivables Corporation and Three Pillars Funding LLC, as conduit lenders (collectively, the “Conduits”), SunTrust Bank, The Bank of Tokyo-Mitsubishi, UFJ, Ltd., New York Branch
(“BTMU”) and PNC Bank, National Association (“PNC”), as liquidity banks, 

 
(collectively, the “Liquidity Banks”), SunTrust Robinson Humphrey, Inc. (“STRH”), as a co-agent and lc participant, The Bank of
Tokyo-Mitsubishi, UFJ, Ltd., New York Branch, as a co-agent and lc participant, and PNC Bank, National Association, as a co-agent, lc bank and as administrative agent (in such latest capacity, the “Administrative Agent”).

 (b) Section 1.3(d) of the Receivables Sale Agreements is replaced in its entirety with the
following: 
 (d) Payment of Purchase Price. The Purchase Price for the initial Purchase shall be paid on
the Purchase Date therefor, and the Purchase Price for each subsequent Purchase shall be paid on the next Settlement Date after the Purchase Date therefor, in each case, by means of any one or a combination of the following: (i) a credit from
the Buyer to the Originator on the books and records of the Parent in an amount not to exceed the lesser of the Purchase Price and the cash then available to the Buyer, (ii) a Subordinated Loan in a principal amount equal to the Deferred
Purchase Price (if any) payable to the Originator and (iii) at the request of the Originator, by causing the LC Bank to issue a Letter of Credit, subject to the terms and conditions (including any limitations therein on the amount of any such
issuance) for issuing Letters of Credit under the Credit and Security Agreement, in favor of beneficiaries selected by the Originator in the face amount requested by the Originator. The face amount of each Letter of Credit shall be applied as a
deduction from the applicable purchase price that would otherwise be payable by the Buyer; provided, however, that in the event that any such Letter of Credit issued (A) expires or is cancelled or otherwise terminated with all or
any portion of its stated amount undrawn, (B) has its stated amount decreased (for a reason other than a drawing having been made thereunder) or (C) the Buyer’s Reimbursement Obligation in respect thereof is reduced for any reason
other than by virtue of a payment made in respect of a drawing thereunder, then an amount equal to such undrawn amount or such reduction, as the case may be, shall either be paid in cash by the Buyer to the Originator on the next Purchase Date or,
if the Buyer does not then have cash available therefor, shall be deemed to be added to the outstanding principal amount of the Subordinated Note issued to the Originator. The allocation of the Purchase Price as among such methods of payment
shall be subject in each instance to the approval of the Buyer and the Originator; provided, however, that the aggregate outstanding principal balance of all Subordinated Loans may not be increased to the extent that, after giving
effect to such increase, the Tangible Net Worth of Buyer would be less than the Required Capital Amount; provided, further, however, that prior to paying any portion of the Purchase Price pursuant to the method set forth in
clause (ii) above, the Purchase Price shall first be paid by the methods set forth in (x) clause (i) above (to the extent the Buyer then has cash available therefore and (y) clause (iii) above to the
extent that the Originator has requested that the Borrower provide it or its 

  
 2 

 
designee with a Letter of Credit and such Letter of Credit is issued to the Borrower or its designee under the Credit and Security Agreement. The obligations of the Buyer in respect of the
Subordinated Loans shall be evidenced by a Subordinated Note payable to the Originator. 
 (c) The following new
Section 1.4(g) is added to the Receivables Sale Agreements immediately following existing Section 1.4(f) thereof: 
 (g) Letters of Credit. In the event the Originator requests that any purchases hereunder be paid for by the issuance of Letters of Credit as described in Section 1.3(d), the Originator
shall, on a timely basis, provide Buyer with such information as is necessary for Buyer to obtain such Letter of Credit from the LC Bank. Neither the Originator nor any beneficiary selected by the Originator shall have any reimbursement obligations
in respect of any such Letter of Credit; provided, however, that the Originator agrees to be bound by (and to cause any applicable designee thereof named as the “Applicant” or “Account Party” of any Letter of Credit
to be bound by) the terms of each Letter of Credit Application and by the LC Bank’s interpretations of any Letter of Credit issued for the Buyer and by the LC Bank’s written regulations and customary practices relating to letters of
credit.  
 (d) Section 2.1(i) of the Receivables Sale Agreements is amended by replacing the
term “Initial Cut-Off Date” where it appears therein with the term “Initial Cutoff Date”. 

(e) Section 2.1(l) of the Receivables Sale Agreements is amended by inserting the following sentence
immediately following the fourth sentence thereof: 
 All payments on the Private Receivables originated by the Originator are
paid either into one of the Originator’s Local Deposit Accounts, a Lock-Box or directly to the Concentration Account. 
 (f) Section 2.1(r) of the Receivables Sale Agreements is amended by replacing the reference to “Section 4.1(a)(viii)” where it appears therein with a reference to
“Section 4.1(b)(ii)”. 
 (g) The first sentence of Section 7.1(b) of the Receivables
Sale Agreements is replaced in its entirety with the following: 
 No provision of this Agreement may be amended,
supplemented, modified or waived except in writing signed by the Administrative Agent, each Lender, the Originator and Buyer. 
 (h) Section 2.1 of the Receivables Sale Agreements is amended by adding thereto the following new clause (w) immediately following existing clause (v) thereof:

  
 3 

  
 (w)
Ordinary Course. In the event that, contrary to the mutual intent of the Originator and the Buyer, any Purchase of Gift Shop Receipts, Purchased Receivables and/or Participation Interests hereunder is not characterized as a sale or
contribution but rather as a collateral transfer for security (or the transactions contemplated hereby are characterized as a financing transaction), each remittance of Collections by (or on behalf of) the Originator will have been (i) in
payment of a debt incurred by the Originator in the ordinary course of business or financial affairs of the Originator and (ii) made in the ordinary course of business or financial affairs of the Originator. 

(i) Clause (iv) of Section 7.4(b) of the Receivables Sale Agreements is replaced in its entirety
with the following: 
 (iv) to any Commercial Paper dealer for or provider of a surety, guaranty or credit or
liquidity enhancement to a Conduit or any entity organized for the purpose of purchasing, or making loans secured by financial assets for which the Administrative Agent, the LC Bank, any Co-Agent, Liquidity Bank, LC Participant or any of their
respective Affiliates acts as the administrator, and 
 (j) Section 7.10(b) of the Receivables Sale
Agreements is amended as follows: 
 (i) the phrase “the Administrative Agent and each Lender” is
inserted at the end of the second sentence thereof; 
 (ii) the phrase “but with the prior written consent
of the Administrative Agent and each Lender” is inserted at the end of the third sentence thereof; and 

(iii) the phrase “be a third party beneficiary hereof and” is inserted in the fifth sentence thereof immediately
prior to the phrase “have the right to enforce this Agreement”. 
 (k) The definition of
“Alternative Base Rate” set forth in Exhibit I to the Receivables Sale Agreements is amended by replacing the term “Wachovia” where such term appears therein with the term “Administrative
Agent”. 
 (l) The defined term “New Sweep Account” set forth in Exhibit I to
the Receivables Sale Agreements is changed to “Blocked Sweep Account” and each reference in the Receivables Sale Agreements to “New Sweep Account” is replaced with a reference to “Blocked Sweep Account”.

 (m) The following new defined terms are hereby added to Exhibit I to the Receivables Sale Agreements in
the appropriate alphabetical order: 

  
 4 

  

“Discount” means with respect to any Purchase, an amount equal to the product of
(x) the Outstanding Balance of the Receivables that are the subject of such Purchase, times (y) the Discount Factor at such time. 
 “Net Billings” means, with respect to any Originator, the aggregate amount of invoices billed to Obligors by or on behalf of such Originator. 

3. Amendment to the McAllen Receivables Sale Agreement. Exhibit III of the McAllen Receivables Sale Agreement is
replaced in its entirety with Exhibit III attached hereto. 
 4. Representations and Warranties. The
Originators and the Buyers hereby represent and warrant to each of the parties hereto as follows: 
 (a)
Representations and Warranties. The representations and warranties contained in Article II of the Receivables Sale Agreements are true and correct as of the date hereof. 

(b) Enforceability. The execution and delivery by each of the Originators and each of the Buyers of this Amendment,
and the performance of each of its obligations under this Amendment and the applicable Receivables Sale Agreement, as amended hereby, are within each of its organizational powers and have been duly authorized by all necessary action on each of its
parts. This Amendment and the applicable Receivables Sale Agreement, as amended hereby, are each of the Originators’ and each of the Buyers’ valid and legally binding obligations, enforceable in accordance with its terms. 

(c) No Default. Both before and immediately after giving effect to this Amendment and the transactions contemplated
hereby, no Termination Event or Unmatured Termination Event exists or shall exist. 
 5. Effect of Amendment;
Ratification. Except as specifically amended hereby, each of the Receivables Sale Agreements are hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect. On and after the Effective Date
(as defined below), all references in each of the Receivables Sale Agreements (or in any other Transaction Document) to “this Agreement”, “hereof”, “herein” or words of similar effect referring to a Receivables Sale
Agreement shall be deemed to be references to such Receivables Sale Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Receivables Sale
Agreements other than as set forth herein. 
 6. Effectiveness. This Amendment shall become effective as of the
date hereof (the “Effective Date”) subject to the conditions precedent that (i) the Administrative Agent receives each of the following: (A) counterparts of this Amendment (whether by facsimile or otherwise) executed by
each of the other parties hereto, in form and substance satisfactory to the Administrative Agent in its sole discretion and (B) such other agreements, documents, opinions and instruments as the Administrative Agent shall request and
(ii) each of the conditions precedent to the effectiveness of the Credit and Security Agreement shall have been satisfied. 

  
 5 

  
 7.
Counterparts. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall
constitute but one and the same instrument. 
 8. Governing Law; Jurisdiction; Waiver of Jury Trial. 

8.1 THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO
THE PRINCIPLES OF CONFLICTS OF LAWS THEREOF. 
 8.2 EACH PARTY TO THIS AGREEMENT HEREBY IRREVOCABLY SUBMITS TO
THE NON-EXCLUSIVE JURISDICTION OF ANY UNITED STATES FEDERAL OR NEW YORK STATE COURT SITTING IN THE BOROUGH OF MANHATTAN, NEW YORK, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY DOCUMENT EXECUTED BY SUCH PERSON
PURSUANT TO THIS AGREEMENT, AND EACH SUCH PARTY HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT AND IRREVOCABLY WAIVES ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO
THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM. ANY JUDICIAL PROCEEDING BY ANY BUYER OR ANY AFFILIATE THEREOF AGAINST ANY PARTY HERETO INVOLVING, DIRECTLY OR INDIRECTLY, ANY
MATTER IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT OR ANY DOCUMENT EXECUTED BY SUCH BUYER OR AFFILIATE THEREOF PURSUANT TO THIS AMENDMENT SHALL BE BROUGHT ONLY IN A COURT IN THE BOROUGH OF MANHATTAN, NEW YORK. 

8.3 EACH PARTY HERETO HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER
(WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT, ANY DOCUMENT EXECUTED BY ANY PARTY HERETO PURSUANT TO THIS AMENDMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.

 9. Section Headings. The various headings of this Amendment are included for convenience only and shall not
affect the meaning or interpretation of this Amendment, the Receivables Sale Agreements or any provision hereof or thereof. 

10. Successors and Assigns. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and
their respective successors and assigns. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 6 

  
 IN WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the date first written above. 
  

			
	 ORIGINATORS
  

AIKEN REGIONAL MEDICAL CENTERS, INC.

AUBURN REGIONAL MEDICAL CENTERS, INC.

DISTRICT HOSPITAL PARTNERS, L.P.
 FORT
DUNCAN MEDICAL CENTER, L.P.
 LANCASTER HOSPITAL CORPORATION
 LAREDO REGIONAL MEDICAL CENTER, L.P.
 MANATEE MEMORIAL HOSPITAL, L.P.

MCALLEN HOSPITALS, L.P.
 NORTHWEST
TEXAS HEALTHCARE SYSTEMS,
 INC.
 SPARKS FAMILY HOSPITAL, INC.
 SUMMERLIN HOSPITAL MEDICAL CENTER LLC

UHS OF OKLAHOMA, INC.
 UHS-CORONA,
INC.
 UNIVERSAL HEALTH SERVICES OF RANCHO SPRINGS, INC.
 VALLEY HEALTH SYSTEM LLC
 WELLINGTON REGIONAL MEDICAL CENTER,

INCORPORATED

		
	 By:
	 	/s/ CHERYL K. RAMAGANO
	 Name:
	 	Cheryl K. Ramagano
	 Title:
	 	Treasurer

  

					
		 	S-1	 	 Omibus Amendment to
 Receivables Sale Agreements

  
 
			
	 BUYERS
  

AIKEN REGIONAL RECEIVABLES, L.L.C.

AUBURN REGIONAL RECEIVABLES, L.L.C.

DISTRICT HOSPITAL PARTNERS RECEIVABLES,

L.L.C.
 FORT DUNCAN MEDICAL
RECEIVABLES, L.L.C.
 LANCASTER HOSPITAL RECEIVABLES, L.L.C.
 LAREDO REGIONAL RECEIVABLES, L.L.C.
 MANATEE MEMORIAL RECEIVABLES, L.L.C.

MCALLEN HOSPITALS RECEIVABLES, L.L.C.

NORTHWEST TEXAS HEALTHCARE RECEIVABLES, L.L.C.
 SPARKS FAMILY HOSPITAL RECEIVABLES,
 L.L.C.

SUMMERLIN HOSPITAL RECEIVABLES, L.L.C.

UHS OF OKLAHOMA RECEIVABLES, L.L.C.

UHS-CORONA RECEIVABLES, L.L.C.
 RANCHO
SPRINGS RECEIVABLES, L.L.C.
 VALLEY HEALTH SYSTEM RECEIVABLES, L.L.C.
 WELLINGTON REGIONAL RECEIVABLES, L.L.C.

		
	 By:
	 	/s/ CHERYL K. RAMAGANO
	 Name:
	 	Cheryl K. Ramagano
	 Title:
	 	Treasurer

  

					
		 	S-2	 	 Omibus Amendment to
 Receivables Sale Agreements

  
 SCHEDULE I 

RECEIVABLES SALE AGREEMENTS 
  

	1.	Receivables Sale Agreement, dated as of August 31, 2007, between Aiken Regional Medical Centers, Inc., a South Carolina corporation (an
“Originator”), and Aiken Regional Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	2.	Receivables Sale Agreement, dated as of August 31, 2007, between Auburn Regional Medical Center, Inc., a Washington corporation (an “Originator”),
and Auburn Regional Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	3.	Receivables Sale Agreement, dated as of August 31, 2007, between District Hospital Partners, L.P., a District of Columbia limited partnership (an
“Originator”), and District Hospital Partners Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	4.	Receivables Sale Agreement, dated as of August 31, 2007, between Fort Duncan Medical Center, L.P., a Delaware limited partnership (an
“Originator”), and Fort Duncan Medical Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	5.	Receivables Sale Agreement, dated as of August 31, 2007, between Lancaster Hospital Corporation, a California corporation (an “Originator”), and
Lancaster Hospital Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	6.	Receivables Sale Agreement, dated as of August 31, 2007, between Laredo Regional Medical Center, L.P., a Delaware limited partnership (an
“Originator”), and Laredo Regional Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	7.	Receivables Sale Agreement, dated as of August 31, 2007, between Manatee Memorial Hospital, L.P., a Delaware limited partnership (an
“Originator”), and Manatee Memorial Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	8.	Receivables Sale Agreement (the “McAllen Receivables Sale Agreement”), dated as of August 31, 2007, between McAllen Hospitals, L.P., a Delaware
limited partnership (an “Originator”), and McAllen Hospitals Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

 

	9.	 Receivables Sale Agreement, dated as of August 31, 2007, between Northwest Texas Healthcare System, Inc., a Texas corporation (an
“Originator”), and 

  
 Schedule I-1

	 	 
Northwest Texas Healthcare Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

 

	10.	Receivables Sale Agreement, dated as of August 31, 2007, between Sparks Family Hospital, Inc., a Nevada corporation (an “Originator”), and Sparks
Family Hospital Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	11.	Receivables Sale Agreement, dated as of August 31, 2007, between Summerlin Hospital Medical Center LLC, a Delaware limited liability company (an
“Originator”), and Summerlin Hospital Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	12.	Receivables Sale Agreement, dated as of August 31, 2007, between UHS of Oklahoma, Inc., an Oklahoma corporation (an “Originator”), and UHS of
Oklahoma Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	13.	Receivables Sale Agreement, dated as of August 31, 2007, between UHS-Corona, Inc., a Delaware corporation (an “Originator”), and UHS-Corona
Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	14.	Receivables Sale Agreement, dated as of August 31, 2007, between Universal Health Services of Rancho Springs, Inc., a California corporation (an
“Originator”), and Rancho Springs Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	15.	Receivables Sale Agreement, dated as of August 31, 2007, between Valley Health System LLC, a Delaware limited liability company (an “Originator”),
and Valley Health System Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  

	16.	Receivables Sale Agreement, dated as of August 31, 2007, between Wellington Regional Medical Center, Incorporated, a Florida corporation (an
“Originator”), and Wellington Regional Receivables, L.L.C., a Delaware limited liability company (a “Buyer”). 

  
 Schedule I-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]